HIF-1α and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line

Cancer Science

Volumn 103, Issue 3, 2012, Pages 464-471

  Mo, Ji Hun ^a   Choi, Ik J ^b   Jeong, Woo Jin ^c   Jeon, Eun Hui ^c   Ahn, Soon Hyun ^c  

^a Dankook University College of Medicine   (South Korea)

^b Korea Cancer Center Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; TANESPIMYCIN; HIF1A PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; ADENOCARCINOMA; ANIMAL; GENE SILENCING; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PROTEIN MICROARRAY; THYROID TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA, PAPILLARY; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HSP90 HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; PROTEIN ARRAY ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THYROID NEOPLASMS;

EID: 84859707678     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02181.x     Document Type: Article

References (28)

1. Kilfoy BA, Zheng T, Holford TR et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009; 20: 525-31.
2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-7.
3. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115: 3801-7.
4. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy studys. Cancer 1985; 56: 531-8.
5. Fukunaga FH, Yatani R. Geographic pathology of occult thyroid carcinomas. Cancer 1975; 36: 1095-9.
6. Ito Y, Miyauchi A. Therapeutic strategies for papillary microcarcinoma of the thyroid. Curr Cancer Ther Rev 2005; 1: 7.
7. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 2010; 34: 1222-31.
8. Derwahl M. Linking stem cells to thyroid cancer. J Clin Endocrinol Metab 2011; 96: 610-3.
9. Ahn SH, Henderson Y, Kang Y et al. An orthotopic model of papillary thyroid carcinoma in athymic nude mice. Arch Otolaryngol Head Neck Surg 2008; 134: 190-7.
10. Kurebayashi J, Okubo S, Yamamoto Y et al. Additive antitumor effects of gefitinib and imatinib on anaplastic thyroid cancer cells. Cancer Chemother Pharmacol 2006; 58: 460-70.
11. Bozdech Z, Zhu J, Joachimiak MP, Cohen FE, Pulliam B, DeRisi JL. Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray. Genome Biol 2003; 4: R9.
12. Barczak A, Rodriguez MW, Hanspers K et al. Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res 2003; 13: 1775-85.
13. Schweppe RE, Klopper JP, Korch C et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 2008; 93: 4331-41.
14. Li Z, Bao S, Wu Q et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009; 15: 501-13.
15. Boltze C, Schneider-Stock R, Roessner A, Quednow C, Hoang-Vu C. Function of HSP90 and p23 in the telomerase complex of thyroid tumors. Pathol Res Pract 2003; 199: 573-9.
16. Muchemwa FC, Nakatsura T, Ihn H, Kageshita T. Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma. Br J Dermatol 2006; 155: 582-5.
17. Huang WS, Chin CC, Chen CN et al. Stromal cell-derived factor-1/CXC receptor 4 and b1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J Cell Physiol 2011; DOI: 10.1002/jcp.22831 [Epub ahead of print].
18. Horibe T, Kohno M, Haramoto M, Ohara K, Kawakami K. Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. J Transl Med 2011; 9: 8.
19. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-5.
20. Barnhart BC, Simon MC. Metastasis and stem cell pathways. Cancer Metastasis Rev 2007; 26: 261-71.
21. Yeung TM, Gandhi SC, Bodmer WF. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 2011; 108: 4382-7.
22. Minet E, Mottet D, Michel G et al. Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett 1999; 460: 251-6.
23. Park JW, Yeh MW, Wong MG et al. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines. J Clin Endocrinol Metab 2003; 88: 3346-53.
24. Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)- independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 2007; 25: 207-17.
25. Wang Y, Liu Y, Malek SN, Zheng P. Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 2011; 8: 399-411.
26. Li Z, Rich JN. Hypoxia and hypoxia inducible factors in cancer stem cell maintenance. Curr Top Microbiol Immunol 2010; 345: 21-30.
27. Matsumoto K, Arao T, Tanaka K et al. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res 2009; 69: 7160-4.
28. Burrows N, Resch J, Cowen RL et al. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocr Relat Cancer 2010; 17: 61-72. Mo.